Clinical Trials Browser

Phase 1 × Unknown × Etoposide × Clear all

NCT06164327 2023-12-11

Study of BEBT-908 Combined With Drugs in the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Phase 1 Unknown

Lymphoma, Large B-Cell, Diffuse

NCT05665075 2023-01-03

Natural Killer (NK) Cell Therapy Targeting CD33 in Acute Myeloid Leukemia

Phase 1 Unknown

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT05665114 2023-01-03

Natural Killer(NK) Cell Therapy in r/r AML

Phase 1 Unknown

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT05379647 2022-05-18

Natural Killer (NK) Cell Therapy for B-Cell Malignancies

Phase 1 Unknown

Burkitt Lymphoma, Lymphoma, B-Cell

NCT04346914 2022-05-11

Study of ZKAB001 Combined With Carboplatin and Etoposide in the Extensive Small Cell Lung Cancer

Phase 1 Unknown

Extensive Stage Small Cell Lung Cancer

NCT05001412 2021-08-12

Chemotherapy Combined With Camrelizumab and Apatinib in First-line Treatment of ES-SCLC

Phase 1 Unknown

Extensive Stage Small Cell Lung Cancer

NCT00002887 2013-09-17

Hydroxyurea Plus Combination Chemotherapy in Patients With Non-small Cell Lung Cancer

Phase 1 Unknown

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00004086 2009-06-09

Radiolabeled Monoclonal Antibody, Combination Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory B-Cell Cancer

Phase 1 Unknown

LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Leukemia, Leukemia, Hairy Cell, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma